HRT: European Agencies Scrutinizing New Higher Breast Cancer Risk Data
Executive Summary
A major new study showing that the risk of breast cancer in women taking hormone replacement therapy is double previous estimates has prompted UK and EU regulatory agencies and England’s health technology assessment body to look further into the matter.